Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNT + PD-1 for High-Risk LARC
NCT07214142Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Oct 2025
- Primary completion
- Dec 2027
01
Overview
Phase 2, open-label, single-arm trial in rectal cancer, sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Pathological Complete Response Rate up to 2 months. Planned start Oct 2025; status: not yet recruiting.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07214142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214142.